Evidence suggests that adiponectin confers protective effects against breast cancer progression [37] by activating AMP-Kinase and suppressing PI3K/AKT signaling, thereby inhibiting tumor growth, angiogenesis, and invasion and by inducing cell apoptosis [36, 37]. Here, ADIPOQ is linked to breast cancer.